Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s D&A?
- Neuropace, Inc. (NPCE) reported D&A of $100K in Q2 2026.
- How has Neuropace, Inc.'s D&A changed year-over-year?
- Neuropace, Inc.'s D&A decreased by 0.0% year-over-year, from $100K to $100K.
- What is the long-term trend for Neuropace, Inc.'s D&A?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s D&A has grown at a -1.7% compound annual growth rate (CAGR), from $353K to $329K.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Neuropace, Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude